You are here: Home Courses & Events Lecture series "Career & …

Career & Development

Wednesday, 11-12 c.t., lecture hall pharmacy, Hermann-Herder-Str. 7, 79104 Freiburg


Winter term 2017/18

 

  • 18.10.2017: Dr. Eva Oswald, Lab Head Cellular Science, Charles River, Freiburg
  • 25.10.2017: Dr. Carolin von Schoultz, Scientific officer, LS2 Life Sciences Switzerland, Bern
  • 08.11.2017: Dr. Heiko Erhardt, Laboratory Scientist, Johnson & Johnson MEDICAL GmbH
  • 15.11.2017: Dr. Thomas Steinbrecher, Senior Applications Scientist, Schrödinger GmbH, Germany
  • 22.11.2017: Dr. Katharina Rauch, Management Start Up Medical Functions, Roche Pharma AG, Grenzach
  • 29.11.2017: Dominik Walther, Apotheker ohne Grenzen
  • 06.12.2017: Jun.-Prof. Dr. Jennifer Andexer, Institute of Pharmaceutical Sciences, University Freiburg
  • 13.12.2017
  • 20.12.2017: Dr. Robert Neugebauer, Pharmaceutical Development Leader, Elanco Deutschland, Bad Homburg
  • 10.01.2018: Dr. Laura van Niftrik, Assistant Professor at Radboud University, Nijmegen, NL
  • 17.01.2018: Dr. Heinrich Schell, Clinical Liaison Manager Oncology, Lilly Deutschland, Bad Homburg
  • 31.01.2018: Dr. Jochen Rupp, Senior Product Manager Labordiagnostik, Bosch Healthcare Solutions, Waiblingen

 

Winter term 2016/17

 

  • 19.10.2016:    Dr. Kurt Wilhelm Stahl, Waisenmedizin e.V. Freiburg, Germany
  • 26.10.2016:    Dr. Michael Breuer, BASF SE, Ludwigshafen, Germany
  • 02.11.2016:    Dr. Eduard Frick, Sigma-Aldrich Production GmbH, Buchs, Switzerland
  • 09.11.2016:    Dr. Helen Potter, Royal Society of Chemistry (RSC), Cambridge, United Kingdom
  • 16.11.2016:    Dr. Martin Schulte, Syngenta Agro GmbH, Maintal, Germany
  • 23.11.2016:    Dr. Jens Fuchser, Bruker Daltonik GmbH, Bremen, Germany
  • 30.11.2016:    Dr. Stefanie Bold, Novartis, Pharma AG, Basel, Switzerland
  • 07.12.2016:    Dr. Marius Löppenberg, MSD, Haar, Germany
  • 18.01.2017:    Dr. Richard Pauptit, Associate Director and Senior Principal Scientist, AstraZeneca, UK (retired)
  • 25.01.2017:    Dr. Patrick Chène, Director, Head of Biochemistry, Oncology Department, Novartis, Switzerland
  • 01.02.2017:    Dr. Dennis A. Effertz, Abrechnungszentrum Emmendingen, Germany (Language: German)